Medifocus Inc

Type: Company
Name: Medifocus Inc
First reported Oct 27 2014 - Updated Oct 27 2014 - 1 reports

MEDIFOCUS : Announces Its Sponsorship at the VM Medical 20th Anniversary Breast Cancer Conference October 23rd and 24th

The Pivotal Phase III breast cancer treatment study has been approved by both the USA Food and Drug Administration and also the Canadian Bureau of Medical Devices (BMD). Dr. John R. Keyserlingk , MD, is the Principal Investigator in Canada at the VM Med ... [Published 4 Traders - Oct 27 2014]
First reported Oct 23 2014 - Updated Oct 23 2014 - 2 reports

Medifocus, Inc. Announces Its Sponsorship at the VM Medical 20th Anniversary Breast Cancer Conference October 23rd and 24th

Poster Presentation Outlining the Pivotal Phase III Clinical Study Currently Being Investigated at VM Medical, the Largest Non Public Private Breast Center in CanadaCOLUMBIA, MD and TORONTO, ON--(Marketwired - Oct 23, 2014) - Medifocus Inc. (OTCQX: MDFZF) ... [Published Scottrade - Oct 23 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Medifocus Inc. Announces Closing of Private Placement

COLUMBIA, MD and TORONTO, ON--(Marketwired - Sep 15, 2014) -  Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today the closing of a private placement of 10,281,250 Units at a price of US$0.16 per Unit for gross proceeds of US$1,645,000. ... [Published Marketwire - Breaking News Releases - Sep 15 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Medifocus, Inc. Announces Financial Results for the Fiscal First Quarter Ending June 30, 2014

Revenues Increase 32% Over Prior Year First Quarter ... [Published Marketwire - Breaking News Releases - Sep 10 2014]
Entities: Medifocus Inc
First reported Sep 08 2014 - Updated Sep 09 2014 - 2 reports

Medifocus Announces Retraction of Prior Press Release

<p style="text-align:left;"&gt;COLUMBIA, MARYLAND and TORONTO, ONTARIO--(Marketwired - Sept. 8, 2014) - Medifocus Inc. (TSX VENTURE:MFS)(OTCQX:MDFZF) ( Medifocus) issued a press release earlier today regarding the initiation of research coverage by ... [Published Marketwire - Breaking News Releases - Sep 09 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Medifocus, Inc. Announces Financial Results for the Fiscal Year and Fiscal Fourth Quarter Ending March 31, 2014

Revenues Reach Record $5.4M for Fiscal 2014, 198% Increase Over the Prior Year While 4th Quarter Revenues Increase 31% From the 3rd Quarter ... [Published Marketwire - Breaking News Releases - Jul 30 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Medifocus, Inc. Is Issued New U.S. Patent Titled, "Apparatus and Method for Pre-Conditioning /Fixation and Treatment of Disease With Heat Activation/Release With Thermoactivated Drugs and Gene Products"

COLUMBIA, MD and TORONTO, ON--(Marketwired - Jul 9, 2014) - Medifocus Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce that on July 1st, 2014, it was issued a new patent by the United States Patent and Trademark Office (USPTO). Medifocus ... [Published Marketwire - Breaking News Releases - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Medifocus, Inc. Featured in Article in "BioTuesdays" Titled, "Medifocus Readies Marketing Expansion of Prolieve"

COLUMBIA, MD and TORONTO, ON--(Marketwired - Jul 8, 2014) - Medifocus, Inc . (OTCQX: MDFZF) (TSX VENTURE: MFS) is pleased to announce that it is featured in today's BioTuesday titled, "Medifocus Readies Market Expansion of Prolieve." Prolieve is ... [Published Marketwire - Breaking News Releases - Jul 08 2014]
First reported Jun 17 2014 - Updated Jun 17 2014 - 1 reports

Medifocus Inc. Announces Extension of Warrants

TORONTO, ONTARIO--(Marketwired - June 17, 2014) - Medifocus Inc. ( Medifocus or the Company ) (TSX VENTURE:MFS)(OTCQX:MDFZF) is pleased to announce that it has applied to the TSX Venture Exchange (the Exchange ) to extend the expiry date of 13,056,997 ... [Published Marketwire - Breaking News Releases - Jun 17 2014]
First reported May 30 2014 - Updated May 30 2014 - 1 reports

Medifocus Inc. Announces Extension of Warrants

TORONTO, ONTARIO--(Marketwired - May 30, 2014) - Medifocus Inc. ( Medifocus or the Company ) (TSX VENTURE:MFS)(OTCQX:MDFZF) is pleased to announce that it has applied to the TSX Venture Exchange (the Exchange ) to extend the expiry date of 18,367,253 ... [Published Marketwire - Breaking News Releases - May 30 2014]
First reported May 27 2014 - Updated May 27 2014 - 1 reports

Medifocus, Inc. to Present at the SeeThruEquity 3rd Annual Microcap Investor Conference and the Third Annual Marcum MicroCap Conference

COLUMBIA, MD and TORONTO, ON--(Marketwired - May 27, 2014) - Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today that, to increase investor's awareness and Medifocus, Inc.'s visibility in the U.S. capital markets, it will present at ... [Published Marketwire - Breaking News Releases - May 27 2014]
First reported May 22 2014 - Updated May 23 2014 - 1 reports

Medifocus Inc. To Present At The Third Annual Marcum MicroCap Conference

COLUMBIA, Md. and TORONTO, May 22, 2014 /PRNewswire/ -- Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) announced today that John Mon, Chief Operating Officer will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, ... [Published PR Newswire: General Business - May 22 2014]

Quotes

Dr. Augustine Y Cheung , President and CEO, stated, "We are very pleased to be part of this breast cancer conference. We are taking steps to refocus our resources so that Medifocus will become a Total Breast Disease Management Company . We firmly believe that the progress we have been making in our breast cancer clinical trials will ultimately be reflected in increased shareholder value."
...In addition, Medifocus will present a Poster on its "Wide-Field Focused Microwave Thermotherapy in Combination with Neoadjuvant Anthracycline-based Chemotherapy to Increase Local Response for Improved Breast Conservation Potential. The Pivotal Phase III breast cancer treatment study has been approved by both the USA FoodFood and Drug Administration and also the Canadian Bureau of Medical Devices (BMD). Dr JohnJohn R Keyserlingk, MD, is the Principal Investigator in Canada at the VM Med (Ville Marie Medical Center) in Montreal, Canada. The USA Principal Investigational site has already been initiated at the University of Oklahoma Breast Institute under the supervision of our USA Principal Investigator, Dr. William C Dooley, MD. The goal of the 238-patient Medifocus-sponsored randomized Phase III study is to demonstrate that preoperative focused microwave heat treatment and chemotherapy combined are more effective than preoperative chemotherapy alone in the treatment of large breast cancer tumors in the intact breast. Combining heat with chemotherapy before surgery might shrink the tumor so that it can be removed in a breast conserving surgery (lumpectomy) thus reducing the need of a mastectomy. Further details of the Medifocus Inc. Pivotal Phase IIIPhase III study are published on the www.clinicaltrials.gov web site. The MedifocusMedifocus Inc. APA-1000 system used in this clinical trial is based on focused microwave thermotherapy technology exclusively licensed from the Massachusetts Institute of Technology (MIT)."
">COLUMBIA, MARYLAND and TORONTO ONTARIO--(Marketwired - Sept. 8, 2014) - Medifocus Inc. (TSX VENTURE:MFS)(OTCQX:MDFZF) ( Medifocus) issued a press release earlier today regarding the initiation of research coverage by SeeThruEquity that inadvertently included a target price from the research report. Medifocus hereby retracts this press release. "
Medifocus Inc. Is Issued New U S Patent Titled, "Apparatus and Method for Pre-Conditioning /Fixation and Treatment of Disease With Heat Activation/Release With Thermoactivated Drugs and Gene Products"

More Content

All (14) | News (2) | Reports (0) | Blogs (12) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
MEDIFOCUS : Announces Its Sponsorship at the VM... [Published 4 Traders - Oct 27 2014]
Medifocus, Inc. Announces Its Sponsorship at th... [Published Scottrade - Oct 23 2014]
Medifocus, Inc. Announces Its Sponsorship at th... [Published Marketwire - Breaking News Releases - Oct 23 2014]
Medifocus Inc. Announces Closing of Private Pla... [Published Marketwire - Breaking News Releases - Sep 15 2014]
Medifocus, Inc. Announces Financial Results for... [Published Marketwire - Breaking News Releases - Sep 10 2014]
Medifocus Announces Retraction of Prior Press R... [Published Marketwire - Breaking News Releases - Sep 09 2014]
SeeThruEquity Initiates Research Coverage on Me... [Published Marketwire - Breaking News Releases - Sep 08 2014]
Medifocus, Inc. Announces Financial Results for... [Published Marketwire - Breaking News Releases - Jul 30 2014]
Medifocus, Inc. Is Issued New U.S. Patent Title... [Published Marketwire - Breaking News Releases - Jul 09 2014]
Medifocus, Inc. Featured in Article in "BioTues... [Published Marketwire - Breaking News Releases - Jul 08 2014]
Medifocus Inc. Announces Extension of Warrants [Published Marketwire - Breaking News Releases - Jun 17 2014]
Medifocus Inc. Announces Extension of Warrants [Published Marketwire - Breaking News Releases - May 30 2014]
Medifocus, Inc. to Present at the SeeThruEquity... [Published Marketwire - Breaking News Releases - May 27 2014]
Medifocus Inc. To Present At The Third Annual M... [Published PR Newswire: General Business - May 22 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Medifocus, Inc. Announces Its Sponsorship at th... [Published Marketwire - Breaking News Releases - Oct 23 2014]
Poster Presentation Outlining the Pivotal Phase III Clinical Study Currently Being Investigated at VM Medical, the Largest Non Public Private Breast Center in Canada ...
Medifocus Inc. Announces Closing of Private Pla... [Published Marketwire - Breaking News Releases - Sep 15 2014]
COLUMBIA, MD and TORONTO, ON--(Marketwired - Sep 15, 2014) -  Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today the closing of a private placement of 10,281,250 Units at a price of US$0.16 per Unit for gross proceeds of US$1,645,000. ...
Medifocus, Inc. Announces Financial Results for... [Published Marketwire - Breaking News Releases - Sep 10 2014]
Revenues Increase 32% Over Prior Year First Quarter ...
Medifocus Announces Retraction of Prior Press R... [Published Marketwire - Breaking News Releases - Sep 09 2014]
<p style="text-align:left;"&gt;COLUMBIA, MARYLAND and TORONTO, ONTARIO--(Marketwired - Sept. 8, 2014) - Medifocus Inc. (TSX VENTURE:MFS)(OTCQX:MDFZF) ( Medifocus) issued a press release earlier today regarding the initiation of research coverage by ...
SeeThruEquity Initiates Research Coverage on Me... [Published Marketwire - Breaking News Releases - Sep 08 2014]
COLUMBIA, MD and TORONTO, ON--(Marketwired - Sep 8, 2014) - Medifocus, Inc. (OTCQX: MDFZF) (TSX VENTURE: MFS) announced today that SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.